The dual personality of iron chelators: Growth inhibitors or promoters?

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2432-2433

  Visca, Paolo ^a   Bonchi, Carlo ^a   Minandri, Fabrizia ^a   Frangipani, Emanuela ^a   Imperi, Francesco ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE MESYLATE; PYOCHELIN; PYOVERDINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; GROWTH INHIBITION; IRON TRANSPORT; LETTER; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; IRON CHELATING AGENTS;

EID: 84876216561     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02529-12     Document Type: Letter

References (14)

1. Nairz M, Schroll A, Sonnweber T, Weiss G. 2010. The struggle for iron - a metal at the host-pathogen interface. Cell. Microbiol. 12:1691-1702.
2. Wandersman C, Delepelaire P. 2004. Bacterial iron sources: from siderophores to hemophores. Annu. Rev. Microbiol. 58:611-647.
3. Ratledge C. 2007. Iron metabolism and infection. Food Nutr. Bull. 28(Suppl 4):S515-S523.
4. Thompson MG, Corey BW, Si Y, Craft DW, Zurawski DV. 2012. Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob. Agents Chemother. 56:5419-5421.
5. de Léséleuc L, Harris G, KuoLee R, Chen W. 2012. In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob. Agents Chemother. 56:5397-5400.
6. Kontoghiorghes GJ, Kolnagou A, Skiada A, Petrikkos G. 2010. The role of iron and chelators on infections in iron overload and non-iron loaded conditions: prospects for the design of new antimicrobial therapies. Hemoglobin 34:227-239.
7. Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl. Acad. Sci. U. S. A. 102:11076-11081.
8. Cuív PO, Keogh D, Clarke P, O'Connell M. 2007. FoxB of Pseudomonas aeruginosa functions in the utilization of the xenosiderophores ferrichrome, ferrioxamine B, and schizokinen: evidence for transport redundancy at the inner membrane. J. Bacteriol. 189:284-287.
9. Poole K, McKay GA. 2003. Iron acquisition and its control in Pseudomonas aeruginosa: many roads lead to Rome. Front. Biosci. 8:661-686.
10. Cornelis P, Matthijs S. 2002. Diversity of siderophore-mediated iron uptake systems in fluorescent pseudomonads: not only pyoverdines. Environ. Microbiol. 4:787-798.
11. He J, Baldini RL, Déziel E, Saucier M, Zhang Q, Liberati NT, Lee D, Urbach J, Goodman HM, Rahme LG. 2004. The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc. Natl. Acad. Sci. U. S. A. 101:2530-2535.
12. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B. 2009. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180:138-145.
13. Bodilis J, Ghysels B, Osayande J, Matthijs S, Pirnay JP, Denayer S, De Vos D, Cornelis P. 2009. Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ. Microbiol. 11:2123-2135.
14. Cobessi D, Celia H, Pattus F. 2005. Crystal structure at high resolution of ferric-pyochelin and its membrane receptor FptA from Pseudomonas aeruginosa. J. Mol. Biol. 352:893-904.